Latest Developments In Techniques And Procedures Used In The Identification And Control Of Contaminants, 30-31 January 2013, London

Date: Oct-02-2012Microbiological contamination of products and processes in a lab and manufacturing environment continues to be a major problem to the Pharmaceutical and Biotechnological industries and its regulators. The potential impact of such contamination can be enormous, and does not only create health and safety problems but can also cost companies millions in lost product revenue.

Regulators will endeavour to ensure that the safety of the health care consumer is never compromised. Aseptic processing attracts a high level of regulatory scrutiny due to the risks associated with this type of manufacturing and its potential adverse effect on the health care consumer

SMi's Pharmaceutical Microbiology conference will aim to provide an expert and highly accredited speaker line up including 13 pharma speakers who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry. Attending will enable you to:
Discuss developments in tools, techniques and procedures used in identification and control of contaminants

Evaluate the handling of traditional drug and biologics & sterile product manufacturing 

Hear about design, construction and validation of sterile facilities and equipment

Engage with those currently working on producing the rapid microbial methods

30th January to 31st January 2013, London, United Kingdom

For more information visit  alternatively contact Farhaana Rahman on +44 0 207 827 6186 or email on frahman@smi-online.co.uk

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.